CO5210906A1 - IMUNOGENOS QUE CONTIENEN PEPTIDOS DEL DOMINO CE2 DE IgE PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES ALERGICAS - Google Patents
IMUNOGENOS QUE CONTIENEN PEPTIDOS DEL DOMINO CE2 DE IgE PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES ALERGICASInfo
- Publication number
- CO5210906A1 CO5210906A1 CO00013394A CO00013394A CO5210906A1 CO 5210906 A1 CO5210906 A1 CO 5210906A1 CO 00013394 A CO00013394 A CO 00013394A CO 00013394 A CO00013394 A CO 00013394A CO 5210906 A1 CO5210906 A1 CO 5210906A1
- Authority
- CO
- Colombia
- Prior art keywords
- ige
- treatment
- imunogens
- domino
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9904405.9A GB9904405D0 (en) | 1999-02-25 | 1999-02-25 | Vaccine |
GBGB9907151.6A GB9907151D0 (en) | 1999-03-29 | 1999-03-29 | Therapeutic antibody composition and use |
GBGB9910538.9A GB9910538D0 (en) | 1999-05-07 | 1999-05-07 | Therapeutic antibody, Immunogenic compositions ansd uses |
GBGB9910537.1A GB9910537D0 (en) | 1999-05-07 | 1999-05-07 | Therapeutic antibody, Immunogenic compositions and uses |
GBGB9918603.3A GB9918603D0 (en) | 1999-08-07 | 1999-08-07 | Novel peptides |
GBGB9918594.4A GB9918594D0 (en) | 1999-08-07 | 1999-08-07 | Novel peptides |
GBGB9921047.8A GB9921047D0 (en) | 1999-09-07 | 1999-09-07 | Therapeutic antibody, immunogenic compositions & uses |
GBGB9921046.0A GB9921046D0 (en) | 1999-09-07 | 1999-09-07 | Therapeutic antibody composition & use |
GBGB9925619.0A GB9925619D0 (en) | 1999-10-29 | 1999-10-29 | Vaccine |
GBGB9927698.2A GB9927698D0 (en) | 1999-11-23 | 1999-11-23 | Therapeutic antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5210906A1 true CO5210906A1 (es) | 2002-10-30 |
Family
ID=27579426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00013394A CO5210906A1 (es) | 1999-02-25 | 2000-02-25 | IMUNOGENOS QUE CONTIENEN PEPTIDOS DEL DOMINO CE2 DE IgE PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES ALERGICAS |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1155037A1 (zh) |
JP (1) | JP2004538238A (zh) |
KR (1) | KR20020007313A (zh) |
CN (1) | CN1348466A (zh) |
AR (1) | AR029336A1 (zh) |
AU (1) | AU2672700A (zh) |
BR (1) | BR0008963A (zh) |
CA (1) | CA2363637A1 (zh) |
CO (1) | CO5210906A1 (zh) |
CZ (1) | CZ20013082A3 (zh) |
HK (1) | HK1044004A1 (zh) |
HU (1) | HUP0200049A2 (zh) |
IL (1) | IL145024A0 (zh) |
MX (1) | MXPA01008613A (zh) |
NO (1) | NO20014130L (zh) |
NZ (1) | NZ513679A (zh) |
PL (1) | PL350993A1 (zh) |
TR (1) | TR200102506T2 (zh) |
WO (1) | WO2000050460A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9913327D0 (en) * | 1999-06-08 | 1999-08-11 | Smithkline Beecham Biolog | Vaccine |
US6787524B2 (en) | 2000-09-22 | 2004-09-07 | Tanox, Inc. | CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies |
EP1497318A4 (en) * | 2001-04-18 | 2006-03-01 | Dyax Corp | BINDING MOLECULES FOR FC ZONE POLYPEPTIDES |
GB0209878D0 (en) * | 2002-04-30 | 2002-06-05 | Glaxosmithkline Biolog Sa | Vaccine |
WO2008099188A1 (en) * | 2007-02-15 | 2008-08-21 | Astrazeneca Ab | Binding members for ige molecules |
AR065368A1 (es) * | 2007-02-15 | 2009-06-03 | Astrazeneca Ab | Anticuerpos para moleculas de ige |
US9187568B2 (en) | 2009-05-07 | 2015-11-17 | Stallergenes S.A. | Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route |
EP3882274A4 (en) * | 2018-09-21 | 2022-06-29 | Riken | Anti-ige antibody specifically binding to membrane-bound ige antibody of ige antibody-producing b cells and method for diagnosing and treating allergic symptoms using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4171299A (en) * | 1975-04-04 | 1979-10-16 | The Regents Of The University Of California | Polypeptide agents for blocking the human allergic response |
WO1998024808A2 (en) * | 1996-12-06 | 1998-06-11 | THE UNITED STATES OF AMERICA represented by THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH | INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE |
JP2001516009A (ja) * | 1997-07-17 | 2001-09-25 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ガン関連核酸及びポリペプチド |
-
2000
- 2000-02-22 CA CA002363637A patent/CA2363637A1/en not_active Abandoned
- 2000-02-22 TR TR2001/02506T patent/TR200102506T2/xx unknown
- 2000-02-22 BR BR0008963-0A patent/BR0008963A/pt not_active IP Right Cessation
- 2000-02-22 CZ CZ20013082A patent/CZ20013082A3/cs unknown
- 2000-02-22 KR KR1020017010939A patent/KR20020007313A/ko not_active Application Discontinuation
- 2000-02-22 EP EP00905073A patent/EP1155037A1/en not_active Withdrawn
- 2000-02-22 IL IL14502400A patent/IL145024A0/xx unknown
- 2000-02-22 PL PL00350993A patent/PL350993A1/xx unknown
- 2000-02-22 AU AU26727/00A patent/AU2672700A/en not_active Abandoned
- 2000-02-22 WO PCT/EP2000/001455 patent/WO2000050460A1/en not_active Application Discontinuation
- 2000-02-22 CN CN00806614A patent/CN1348466A/zh active Pending
- 2000-02-22 NZ NZ513679A patent/NZ513679A/xx not_active Application Discontinuation
- 2000-02-22 HU HU0200049A patent/HUP0200049A2/hu unknown
- 2000-02-22 MX MXPA01008613A patent/MXPA01008613A/es unknown
- 2000-02-22 JP JP2000601038A patent/JP2004538238A/ja active Pending
- 2000-02-25 AR ARP000100820A patent/AR029336A1/es not_active Application Discontinuation
- 2000-02-25 CO CO00013394A patent/CO5210906A1/es not_active Application Discontinuation
-
2001
- 2001-08-24 NO NO20014130A patent/NO20014130L/no not_active Application Discontinuation
-
2002
- 2002-05-16 HK HK02103724.5A patent/HK1044004A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN1348466A (zh) | 2002-05-08 |
KR20020007313A (ko) | 2002-01-26 |
PL350993A1 (en) | 2003-02-24 |
TR200102506T2 (tr) | 2002-06-21 |
NO20014130D0 (no) | 2001-08-24 |
NO20014130L (no) | 2001-09-13 |
NZ513679A (en) | 2001-09-28 |
AU2672700A (en) | 2000-09-14 |
MXPA01008613A (es) | 2003-06-24 |
IL145024A0 (en) | 2002-06-30 |
JP2004538238A (ja) | 2004-12-24 |
BR0008963A (pt) | 2001-11-27 |
CA2363637A1 (en) | 2000-08-31 |
EP1155037A1 (en) | 2001-11-21 |
HK1044004A1 (zh) | 2002-10-04 |
HUP0200049A2 (en) | 2002-05-29 |
AR029336A1 (es) | 2003-06-25 |
CZ20013082A3 (cs) | 2002-02-13 |
WO2000050460A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0016022A (pt) | Vacina para a prevenção e tratamento da doença de alzheimer e doenças relacionadas ao amilóide | |
DE69718150T2 (de) | Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien | |
EA200000608A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
AR020019A1 (es) | Composicion farmaceutica para la prevencion o el tratamiento de cancer de mama | |
ES2072323T3 (es) | Compuestos de piperidina y su preparacion y empleo. | |
AR024074A1 (es) | FRAGMENTO ABETA UNIDO A UN PÉPTIDO PORTADOR PARA PREVENIR O TRATAR ENFERMEDADES ASOCIADAS CON DEPoSITOS AMILOIDES DE ABETA, COMPOSICIONES FARMACÉUTICAS QUE LO CONTIENEN, Y SU USO EN LA PREPARACION DE MEDICAMENTOS. | |
PT721449E (pt) | Inibidores da producao da proteina beta-amiloide | |
ATE257386T1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
AR020102A1 (es) | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento | |
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
ATE242633T1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
ES2231826T3 (es) | Anticuerpos monoclonales anti-cd6 para el tratamiento y el diagnostico de la psoriasis. | |
CY1105125T1 (el) | Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων | |
AR023806A1 (es) | Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas | |
MX9304837A (es) | Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico. | |
ATE218581T1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
DE3850649D1 (de) | Immunotherapeutisches zubereitungen für die behandlung von aids. | |
AR003589A1 (es) | Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido. | |
AR008799A1 (es) | Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento | |
ES2177636T3 (es) | Utilizacion del agua empobrecida en deuterio en la preparacion de cosmeticos. | |
BR0211761A (pt) | depsipeptìdeos e processos para preparar os mesmos | |
CO5210906A1 (es) | IMUNOGENOS QUE CONTIENEN PEPTIDOS DEL DOMINO CE2 DE IgE PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES ALERGICAS | |
RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
ES2096988T3 (es) | Organopolisiloxanos que contienen grupos hidrofilos. | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |